CompletedNot Applicable

Full Automaticity and Remote Follow-up

France354 participantsStarted 2011-05

Plain-language summary

With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. This has resulted in an increase of the number of follow-up (FU) to be performed and a growing workload for centers. Remote FU system such as the Medtronic Carelink system allows to check remotely the proper functioning of self evaluating devices and give informations of some clinical events. The objective of this study is to define which patients with a remote follow-up need additional onsite visit and to assess to which extent remote FU can be an alternative to onsite visit.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient older than 18, * Patient implanted with a fully automatic ICD and remotely followed-up, * Patient geographically stable and able to attend FU at investigative site * Patient who signed a data release authorization form, Exclusion Criteria: * Patient whose mental or physical capacity impedes to give an informed data release authorization, * Patient already enrolled in a clinical study whose procedures may interfere with the results of the present study, * Patients in New York Heart Association (NYHA) class IV

What they're measuring

Remote Follow-up as an Alternative to Onsite Visit

Timeframe: 13 months

Trial details

NCT IDNCT01526629

SponsorMedtronic Cardiac Rhythm and Heart Failure

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-03

Results submitted2017-02-14

View on ClinicalTrials.gov More Tachyarrhythmia trials